X

Health Care

CONMED Corp shares slip after Q4 earnings beat, cautious guidance

Shares of CONMED Corporation (NYSE: CNMD) slipped in early trading after the medical technology company reported fourth quarter and full-year…

HCA Healthcare jumps after Q4 profit beat, issues upbeat 2026 outlook and boosts shareholder returns

Share Performance Shares of HCA Healthcare, Inc. (NYSE: HCA) rose in early trade after the company reported fourth quarter 2025 results…

UnitedHealth Group Q4 2025 Earnings Hit by One-Time Charges as Revenue Growth Continues, Shares Slide on Cautious Outlook

UnitedHealth Group (NYSE: UNH) today reported full year and fourth quarter 2025 results and issued its 2026 outlook. “We confronted…

UnitedHealth Group (UNH) Earnings: 4Q25 Key Numbers

UnitedHealth Group (NYSE: UNH) reported its fourth quarter 2025 earnings results today. Total revenues were $113.2 billion compared to $100.8 billion…

Intuitive Surgical reports strong Q4 results; sees slower da Vinci procedure growth in FY26

Intuitive Surgical, Inc. (NASDAQ: ISRG) has reported double-digit growth in revenue and adjusted earnings for the fourth quarter of fiscal…

Intuitive Surgical Reports Strong Preliminary Q4 and Full-Year 2025 Results

Intuitive Surgical (Nasdaq: ISRG) released unaudited preliminary financial results for Q4 and full-year 2025 on Jan 14, 2026, and is…

Abbott Laboratories achieves double-digit earnings growth

Abbott (NYSE: ABT), we're driven by a shared mission: to help you live a healthier, fuller life. The revolutionary health technologies…

Earnings: Highlights of Abbott Laboratories’ (ABT) Q4 2025 report

Medical device maker Abbott Laboratories (NYSE: ABT) on Thursday reported a 4% increase in sales for the fourth quarter of…

Essity Reports Full-Year 2025 Results with Margin Expansion Amid Lower Sales

Essity Aktiebolag (STO: ESSITYB) on Thursday reported its full-year 2025 financial results, highlighting a period of increased profitability and market…

Infographic: How Johnson & Johnson (JNJ) performed in Q4 2025

Johnson & Johnson (NYSE: JNJ) reported its fourth quarter 2025 earnings results today. Reported sales increased 9.1% year-over-year to $24.56…